Role of a redox-based methylation switch in mrna life cycle (preand post-transcriptional maturation) and protein turnover: Implications in neurological disorders

Frontiers in Neuroscience

Volumn , Issue JUN, 2012, Pages

  Trivedi, Malav S ^a   Deth, Richard C ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Alternative splicing; Fmrp; Glutathione; Homeostatis; Redox status; Rett syndrome; S adenosylmethionine; Synaptic scaling

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; GLUTATHIONE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; MESSENGER RNA; MICRORNA; PROTEIN; RIBONUCLEOPROTEIN; RIBOSOME RNA; RNA BINDING PROTEIN; RNA PRECURSOR; SERINE ARGININE RICH PROTEIN; SMALL NUCLEAR RNA; SMALL NUCLEOLAR RNA; TRANSFER RNA; UNTRANSLATED RNA; VIRUS RNA;

ANTIOXIDANT ACTIVITY; BIOGENESIS; DENDRITE; FRAGILE X SYNDROME; HISTOPATHOLOGY; HUMAN; HYPOTHESIS; LIFE CYCLE; LIFESPAN; NERVE CELL; NERVE CELL NETWORK; NEUROLOGIC DISEASE; NONHUMAN; OXIDATION REDUCTION STATE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; PROTEIN PROCESSING; PROTEIN SYNTHESIS; RNA METHYLATION; RNA SPLICING; RNA TRANSPORT; SHORT SURVEY; SIGNAL TRANSDUCTION; SYNAPSE; TRANSCRIPTION REGULATION;

EID: 84865125057     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2012.00092     Document Type: Short Survey

References (67)

1. Antar, L. N., Dictenberg, J. B., Plociniak, M., Afroz, R., and Bassell, G. J. (2005). Localization of FMRPassociated mRNA granules and requirement of microtubules for activity-dependent trafficking in hippocampal neurons. Genes Brain Behav. 4, 350-359.
2. Backlund, P. S., Carotti, D., and Cantoni, G. L. (1986). Effects of the S-adenosylhomocysteine hydrolase inhibitors 3-deazaadenosine and 3deazaaristeromycin on RNA methylation and synthesis. Eur. J. Biochem. 160, 245-251.
3. Banerjee, P., Schoenfeld, B. P., Bell, A. J., Choi, C. H., Bradley, M. P., Hinchey, P., Kollaros, M., Park, J. H., McBride, S. M.,and Dockendorff,T. C. (2010). Shortand long-term memory are modulated by multiple isoforms of the fragile X mental retardation protein. J. Neurosci. 30, 6782-6792.
4. Bedford, M. T., and Clarke, S. G. (2009). Protein arginine methylation in mammals: who, what, and why. Mol. Cell 33, 1-13.
5. Bernstein, E., and Allis, C. D. (2005). RNA meets chromatin. Genes Dev. 19, 1635-1655.
6. Boisvert, F.-M., Côté, J., Boulanger, M.-C., and Richard, S. (2003). A proteomic analysis of argininemethylated protein complexes. Mol. Cell Proteomics 2, 1319-1330.
7. Brostoff, S., and Eylar, E. H. (1971). Localization of methylated arginine in the A1 protein from myelin. Proc. Natl. Acad. Sci. U.S.A. 68, 765-769.
8. Caboche, M., and Bachellerie, J. (1977). RNA methylation and control of eukaryotic RNA biosynthesis. Eur. J. Biochem. 74, 19-29.
9. Cajigas, I. J., Will, T., and Schuman, E. M. (2010). Protein homeostasis and synaptic plasticity. EMBO J. 29, 2746-2752.
10. Chahrour, M., Jung, S. Y., Shaw, C., Zhou, X., Wong, S. T., Qin, J., and Zoghbi, H. Y. (2008). MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320, 1224-1229.
11. Chiang, P. K., Gordon, R. K., Tal, J., Zeng, G. C., Doctor, B. P., Pardhasaradhi, K., and McCann, P. P. (1996). S-adenosylmethionine and methylation. FASEB J. 10, 471-480.
12. Chicurel, M. E., Terrian, D. M., and Potter, H. (1993). mRNA at the synapse: analysis of a synaptosomal preparation enriched in hippocampal dendritic spines. J. Neurosci. 13, 4054-4063.
13. Chuang, J. C., and Jones, P. A. (2007). Epigenetics and microRNAs. Pediatr. Res. 61, 24R-29R.
14. Darnell, J. C.,Van Driesche, S. J., Zhang, C., Hung, K. Y., Mele, A., Fraser, C. E., Stone, E. F., Chen, C., Fak, J. J., Chi, S. W., Licatalosi, D. D., Richter, J. D., and Darnell, R. B. (2011). FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146, 247-261.
15. De Boulle, K., Verkerk, A. J., Reyniers, E.,Vits, L., Hendrickx, J.,Van Roy, B., Van den Bos, F., de Graaff, E., Oostra, B. A., and Willems, P. J. (1993). A point mutation in the FMR-1 gene associated with fragile X mental retardation. Nat. Genet. 3, 31-35.
16. Deth, R., Muratore, C., Benzecry, J., Power-Charnitsky, V.-A., and Waly, M. (2008). How environmental and genetic factors combine to cause autism: a redox/methylation hypothesis. Neurotoxicology 29, 190-201.
17. Dictenberg, J. B., Swanger, S. A., Antar, L. N., Singer, R. H., and Bassell, G. J. (2008). A direct role for FMRP in activity-dependent dendritic mRNA transport links filopodial-spine morphogenesis to fragile X syndrome. Dev. Cell 14, 926-939.
18. Dolzhanskaya, N., Merz, G., Aletta, J. M., and Denman, R. B. (2006). Methylation regulates the intracellular protein-protein and proteinRNA interactions of FMRP. J. Cell. Sci. 119, 1933-1946.
19. Durand, C. M., Betancur, C., Boeckers, T. M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I. C., Anckarsäter, H., Sponheim, E., Goubran-Botros, H., Delorme, R., Chabane, N., MourenSimeoni, M. C., de Mas, P., Bieth, E., Rogé, B., Héron, D., Burglen, L., Gillberg, C., Leboyer, M., and Bourgeron, T. (2007). Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat. Genet. 39, 25-27.
20. Feng, Y., Absher, D., Eberhart, D. E., Brown,V., Malter, H. E., and Warren, S. T. (1997). FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association. Mol. Cell 1, 109-118.
21. Gary, J. D., and Clarke, S. (1998). RNA and protein interactions modulated by protein arginine methylation. Prog. Nucleic Acid Res. Mol. Biol. 61, 65-131.
22. Grabowski, P. J., and Black, D. L. (2001). Alternative RNA splicing in the nervous system. Prog. Neurobiol. 65, 289-308.
23. Heilman, K. L., Leach, R. A., and Tuck, M. T. (1996). Internal 6methyladenine residues increase the in vitro translation efficiency of dihydrofolate reductase messenger RNA. Int. J. Biochem. Cell Biol. 28, 823-829.
24. Hermes, M., Osswald, H., Mattar, J., and Kloor, D. (2004). Influence of an altered methylation potential on mRNA methylation and gene expression in HepG2 cells. Exp. Cell Res. 294, 325-334.
25. Hirrlinger, J., Schulz, J. B., and Dringen, R. (2002). Glutathione release from cultured brain cells: multidrug resistance protein 1 mediates the release of GSH from rat astroglial cells. J. Neurosci. Res. 69, 318-326.
26. James, S. J., Cutler, P., Melnyk, S., Jernigan, S., Janak, L., Gaylor, D. W., and Neubrander, J. A. (2004). Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am. J. Clin. Nutr. 80, 1611-1617.
27. Lacoux, C., Di Marino, D., Pilo Boyl, P., Zalfa, F., Yan, B., Ciotti, M. T., Falconi, M., Urlaub, H., Achsel, T., Mougin, A., Caizergues-Ferrer, M., and Bagni, C. (2012). BC1-FMRP interaction is modulated by 2′-Omethylation: RNA-binding activity of the tudor domain and translational regulation at synapses. Nucleic Acids Res. 40, 4086-4096.
28. Lao, K. Q., Tang, F., Barbacioru, C., Wang, Y., Nordman, E., Lee, C., Xu, N., Wang, X., Tuch, B., Bodeau, J., Siddiqui, A., and Surani, M. A. (2009). mRNA-sequencing whole transcriptome analysisof a single cell on the SOLiDTM system. J. Biomol. Tech. 20, 266-271.
29. Lertratanangkoon, K.,Wu, C. J., Savaraj, N., and Thomas, M. L. (1997). Alterations of DNA methylation by glutathione depletion. Cancer Lett. 120, 149-156.
30. Li, Q., Lee, J.-A., and Black, D. L. (2007). Neuronal regulation of alternative pre-mRNA splicing. Nat. Rev. Neurosci. 8, 819-831.
31. Lipscombe, D. (2005). Neuronal proteins custom designed by alternative splicing. Curr. Opin. Neurobiol. 15, 358-363.
32. Martin, T. T. (1992). The formation of internal 6-methyladenine residues in eucaryotic messenger rna. Int. J. Biochem. 24, 379-386.
33. Mehler, M. F., and Mattick, J. S. (2007). Noncoding RNAs and RNA editing in brain development, functional diversification, and neurological disease. Physiol. Rev. 87, 799-823.
34. Motorin, Y., and Helm, M. (2011). RNA nucleotide methylation. Wiley Interdiscip. Rev. RNA 2, 611-631.
35. Muslimov, I. A., Lin, Y., Heller, M., Brosius, J., Zakeri, Z., and Tiedge, H. (2002). A small RNA in testis and brain: implications for male germ cell development. J. Cell. Sci. 115, 1243-1250.
36. Paik, W. K., and Kim, S. (1968). Protein methylase I purification and properties of the enzymE. J. Biol. Chem. 243, 2108-2114.
37. Petrossian, T. C., and Clarke, S. G. (2011). Uncovering the human methyltransferasome. Mol. Cell Proteomics 10, M110.000976.
38. Qiu, F., and McCloskey, J. A. (1999). Selective detection of ribosemethylated nucleotides in RNA by a mass spectrometry-based method. Nucleic Acids Res. 27, e20.
39. Qureshi, I. A., and Mehler, M. F. (2010). The emerging role of epigenetics in stroke: II. RNA regulatory circuitry. Arch. Neurol. 67, 1435
40. Raps, S. P., Lai, J. C., Hertz, L., and Cooper, A. J. (1989). Glutathione is present in high concentrations in cultured astrocytes but not in cultured neurons. Brain Res. 493, 398-401.
41. Rigoutsos, I., and Furnari, F. (2010). Gene-expression forum: decoy for microRNAs. Nature 465,1016-1017.
42. Rozenski, J., Crain, P. F., and McCloskey, J. A. (1999). The RNA modification database: 1999 update. Nucleic Acids Res. 27, 196-197.
43. Saito, Y., Liang, G., Egger, G., Friedman, J. M., Chuang, J. C., Coetzee, G. A., and Jones, P. A. (2006). Specific activation of microRNA127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9, 435-443.
44. Salmena, L., Poliseno, L., Tay, Y., Kats, L., and Pandolfi, P. P. (2011). A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 146, 353-358.
45. Santoro, M. R., Bray, S. M., and Warren, S. T. (2011). Molecular mechanisms of fragile X syndrome: a twenty-year perspective.Annu. Rev. Pathol. Mech. Dis. 7, 219-245.
46. Schaefer, M., Pollex, T., Hanna, K., and Lyko, F. (2009). RNA cytosine methylation analysis by bisulfite sequencing. Nucleic Acids Res. 37, e12.
47. Shukla, A., Chaurasia, P., and Bhaumik, S. R. (2009). Histone methylation and ubiquitination with their crosstalk and roles in gene expression and stability. Cell. Mol. Life Sci. 66, 1419-1433.
48. Su,Z.,Xia,J.,and Zhao,Z. (2011). Functional complementation between transcriptional methylation regulation and post-transcriptional microRNA regulation in the human genome. BMC Genomics 12, S15. doi:10.1186/1471-2164-12-S5-S15
49. Sudhof, T. C. (2008). Neuroligins and neurexins link synaptic function to cognitive disease. Nature 455, 903-911.
50. Suess, E., Malessa, S., Ungersböck, K., Kitz, P., Podreka, I., Heimberger, K., Hornykiewicz, O., and Deecke, L. (1991). Technetium-99m-d,1hexamethylpropyleneamine oxime (HMPAO) uptake and glutathione content in brain tumors. J. Nucl. Med. 32, 1675-1681.
51. Tuck, M. T., Wiehl, P. E., and Pan, T. (1999). Inhibition of 6methyladenine formation decreases the translation efficiency of dihydrofolate reductase transcripts. Int. J. Biochem. Cell Biol. 31, 837-851.
52. Turrigiano, G. G., and Nelson, S. B. (2004). Homeostatic plasticity in the developing nervous system. Nat. Rev. Neurosci. 5, 97-107.
53. Ufer, C., Wang, C. C., Borchert, A., Heydeck,D.,and Kuhn,H. (2010). Redox control in mammalian embryo development. Antioxid. Redox Signal. 13, 833-875.
54. Vaughan, M. H., Soeiro, R., Warner, J. R., and Darnell, J. E. (1967). The effects of methionine deprivation on ribosome synthesis in HeLa cells. Proc. Natl. Acad. Sci. U.S.A. 58, 1527-1534.
55. Waly, M., Olteanu, H., Banerjee, R., Choi, S. W., Mason, J. B., Parker, B. S., Sukumar, S., Shim, S., Sharma,A., Benzecry, J. M., Power-Charnitsky, V. A., and Deth, R. C. (2004). Activation of methionine synthase by insulin-like growth factor-1 and dopamine: a target for neurodevelopmental toxins and thimerosal. Mol. Psychiatry 9, 358-370.
56. Wang, W., van Niekerk, E., Willis, D. E., and Twiss, J. L. (2007). RNA transport and localized protein synthesis in neurological disorders and neural repair. Dev. Neurobiol. 67, 1166-1182.
57. Warren, S. T. (2011). Trinucleotide repeat syndromes (fragile X). Annu. Rev. Pathol. 7, 110301101326014.
58. Weber, B., Stresemann, C., Brueckner, B., and Lyko, F. (2007). Methylation of human microRNA genes in normal and neoplastic cells. Cell Cycle 6, 1001-1005.
59. Wei, C., and Moss, B. (1977). 5'Terminal capping of RNA by guanylyltransferase from HeLa cell nuclei. Proc. Natl. Acad. Sci. U.S.A. 74, 3758-3761.
60. Wiesen, J. L., and Tomasi, T. B. (2009). Dicer is regulated by cellular stresses and interferons. Mol. Immunol. 46, 1222-1228.
61. Williamson, A. J. K., and Whetton, A. D. (2011). The requirement for proteomics to unravel stem cell regulatory mechanisms. J. Cell. Physiol. 226, 2478-2483.
62. Yi, P., Melnyk, S., Pogribna, M., Pogribny, I. P., Hine, R. J., and James, S. J. (2000). Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J. Biol. Chem. 275, 29318-29323.
63. Young, J. I., Hong, E. P., Castle, J. C., Crespo-Barreto, J., Bowman, A. B., Rose, M. F., Kang, D., Richman, R., Johnson, J. M., Berget, S., and Zoghbi, H. Y. (2005). Regulation of RNA splicing by the methylationdependent transcriptional repressor methyl-CpG binding protein 2. Proc. Natl. Acad. Sci. U.S.A. 102, 17551-17558.
64. Yu, M. C. (2011). The role of protein arginine methylation in mRNP dynamics. Mol. Biol. Int. 2011, 1-10.
65. Zalfa, F., Adinolfi, S., Napoli, I., KühnHölsken, E., Urlaub, H., Achsel, T., Pastore, A., and Bagni, C. (2005). Fragile X mental retardation protein (FMRP) binds specifically to the brain cytoplasmic RNAs BC1/BC200 via a novel RNA-binding motif. J. Biol. Chem. 280, 33403-33410.
66. Zalfa, F., Giorgi, M., Primerano, B., Moro, A., Di Penta, A., Reis, S., Oostra, B., and Bagni, C. (2003). The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses. Cell 112, 317-327.
67. Zang, J. B., Nosyreva, E. D., Spencer, C. M., Volk, L. J., Musunuru, K., Zhong, R., Stone, E. F., Yuva-Paylor, L. A., Huber, K. M., Paylor, R., Darnell, J. C., and Darnell, R. B. (2009). A mouse model of the human fragile X syndrome I304N mutation. PLoS Genet. 5, e1000758. doi:10.1371/journal.pgen.1000758